(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.82%) $83.16
(-1.16%) $1.619
(-0.35%) $2 339.00
(0.93%) $27.51
(0.51%) $926.80
(-0.18%) $0.933
(-0.17%) $11.01
(-0.26%) $0.798
(0.00%) $92.17
Live Chart Being Loaded With Signals
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment...
Stats | |
---|---|
Šios dienos apimtis | 30.59M |
Vidutinė apimtis | 1.41M |
Rinkos kapitalizacija | 2.08B |
EPS | $0 ( 2024-02-20 ) |
Kita pelno data | ( $0 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 75.00 |
ATR14 | $1.147 (2.89%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-09-01 | Wolterman Dan | Sell | 4 816 | Restricted Stock Unit |
2023-09-01 | Raimundo Amy Belt | Sell | 4 816 | Restricted Stock Uni |
2023-09-01 | Norwalk Leslie V | Sell | 3 095 | Common Stock, par value $0.001 per share |
2023-09-01 | Norwalk Leslie V | Sell | 4 816 | Restricted Stock |
2023-09-01 | Kadia Siddhartha | Sell | 3 739 | Common Stock, par value $0.001 per share |
INSIDER POWER |
---|
-41.68 |
Last 100 transactions |
Buy: 498 422 | Sell: 653 864 |
Tūris Koreliacija
NuVasive Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
NuVasive Inc Koreliacija - Valiuta/Žaliavos
NuVasive Inc Finansinės ataskaitos
Annual | 2022 |
Pajamos: | $1.20B |
Bruto pelnas: | $865.44M (72.00 %) |
EPS: | $0.780 |
FY | 2022 |
Pajamos: | $1.20B |
Bruto pelnas: | $865.44M (72.00 %) |
EPS: | $0.780 |
FY | 2021 |
Pajamos: | $1.14B |
Bruto pelnas: | $816.71M (71.70 %) |
EPS: | $-1.240 |
FY | 2020 |
Pajamos: | $1.05B |
Bruto pelnas: | $728.95M (69.39 %) |
EPS: | $-0.720 |
Financial Reports:
No articles found.
NuVasive Inc
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.